Herpes simplex vaccine (Agenus)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHerpes simplex vaccine (Agenus)
Drug Alias NameHerpVrhHSP70-PCAG-707
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCD4-positive T-lymphocytes stimulantsCD8-positive T-Lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes SimplexHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgenus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgenus Inc
Active IndicationsN/A
Inactive IndicationsHerpes SimplexHerpes Genitalis

Other Information

ATC CodeN/A
Related LinksN/A